Technology | 2016.01.19
iTeos Therapeutics Enters Into Therapeutic Antibody Discovery Partnership with Adimab
iTeos Therapeutics SA, a biotechnology company with a track record of delivering therapeutics targeting the immune tumor micro-environment, today announced a new partnership for the discovery, development and commercialization of multiple, antibody-based therapeutic programs with Adimab, LLC.
(PRWeb January 18, 2016)
Read the full story at http://www.prweb.com/releases/2016/01/prweb13165382.htm
For more information, please visit
http://www.prweb.com/releases/2016/01/prweb13165382.htm
